Skip to content
DefDex

Federal award

(RC) 2 PHARMA CONNECT L.L.C.

SPE60123FG16E

Contract

Obligated and Ceiling

Obligated (net)
$0.00
Ceiling (potential value, not spending)
$0.00
Current value
$0.00
Gross positive obligations
$9,267,119.84

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
(RC) 2 PHARMA CONNECT L.L.C. · XCFPGWJXNU83
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
(RC) 2 PHARMA CONNECT L.L.C. · XCFPGWJXNU83
Awarding agency
Department of War · sub-agency 97AS · office SPE601
Funding agency
Department of War · sub-agency 97AS
Product or service (PSC)
9135 · LIQUID PROPELLANT FUELS AND OXIDIZERS, CHEMICAL BASE
Industry (NAICS)
325120 · INDUSTRIAL GAS MANUFACTURING
PIID
SPE60123FG16E
Parent vehicle (IDV PIID)
SPE60123D1501
Award type code
C
Actions
6 · Jan 17, 2023 to Oct 24, 2023
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History6

Award actions
DateFYModAction typeObligationCompany in company totals
Oct 24, 2023FY2024P00005M−$9,267,119.84
—
Oct 18, 2023FY2024P00004M$0.00
—
Oct 18, 2023FY2024P00003M$2,856,377.64
—
Sep 5, 2023FY2023P00002M$112,941.84
—
Jan 17, 2023FY20230—$3,148,900.18
—
Jan 17, 2023FY2023P00001M$3,148,900.18
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.